Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,066

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,786

Class I recallsReasonable probability of serious health consequences

24,313

Class II recallsTemporary or medically reversible health consequences

2,876

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,072 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026

Most affected stateHawaii 200 recalls mention this state

State: AS ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 12, 2026 ET

Summary (Year to date)

1,527 recalls have been announced year to date.
Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,313
Class I	9,786
Class III	2,876
Not Yet Classified	2

FDA Recall Terminated Historical recordClass II

Albuterol (PF/SULFURIC ACID/DYE FREE) - 3ML tube - 0.083% Inhalation Solution, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

5-Fluorouracil 1%, 2.5ML droptainer, and 5ML droptainer Ophthalmic, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Minoxidil 0.75% (1.5ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylcobalamin 1MG/ML (1ML vial); Methylcobalamin 3MG/ML (1ML vial); Methylcobalamin 5MG/ML (1ML vial) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Hydroxocobalamin 25MG/ML (2ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Chlorpheniramine/Hyoscyamine (1ML) 10MG/0.25MG/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dutasteride 0.1% (1.5ML VIAL) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01

by Pfizer Inc.

Reason: Presence of Particulate Matter: Glass particulate matter detected in injectable.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5

by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Reason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Reason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940

by Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Reason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Epinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch as (a)100 G; (b)1 G, (c) 25 G, (d) 5 G; Rx only. Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901.

by Spectrum Laboratory Products, Inc.

Reason: Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose Vial, packaged in 30 x 5 mL Single-Dose Vials per carton, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th Street Extension, W. Columbia, SC 29172, NDC 0487-6105-01, UPC 3 04876 10501 3.

by Nephron Sc Inc

Reason: CGMP Deviations: potential for trace amounts of product carryover.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3.

by Nephron Sc Inc

Reason: CGMP Deviations: potential for trace amounts of product carryover.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9

by Nephron Sc Inc

Reason: Short Fill
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

by Nephron Sc Inc

Reason: Short Fill
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Clobetasol propionate Cream USP, 0.05%, 45 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, India, NDC 68180-956-03

by Lupin Pharmaceuticals Inc.

Reason: Subpotent Drug: Low assay result observed during long-term stability testing.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Metoprolol Succinate Extended-Release Tablets, USP 50 mg, Rx Only, 500 Tablets per bottle, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC, Parsippany NJ 07054, NDC 67877-591-05.

by Ascend Laboratories, LLC

Reason: Failed Dissolution Specification
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

VANCOMYCIN FORTIFIED 10MG/ML (1ML DROPTAINER) OPH SOLUTION VANCOMYCIN FORTIFIED 14MG/ML (3ML DROPTAINER) OPH SOLUTION VANCOMYCIN FORTIFIED-STS- 50MG/ML OPH SOLUTION VANCOMYCIN-STS- 25MG/ML (2ML DROPTAINER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TOBRAMYCIN FORTIFIED 15MG/ML OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

by Pharmacy Innovations

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Published: February 1, 2023
Distribution: Nationwide

View recall →

Data last updated: September 12, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.